[FATE] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -0.37%
YoY- -8.09%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 1,027 1,027 1,026 1,027 1,322 1,076 1,026 0.06%
PBT -10,126 -7,940 -8,737 -8,408 -8,377 -7,446 -6,886 29.28%
Tax 111 -160 37 31 27 -207 4 814.73%
NP -10,126 -7,940 -8,737 -8,408 -8,377 -7,446 -6,886 29.28%
Tax Rate - - - - - - - -
Total Cost 11,153 8,967 9,763 9,435 9,699 8,522 7,912 25.69%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -985.98 -773.13 -851.56 -818.70 -633.66 -692.01 -671.15 29.20%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -0.24 -0.21 -0.27 -0.29 -0.29 -0.26 -0.24 0.00%
EPS Diluted -0.24 -0.21 -0.27 -0.29 -0.29 -0.26 -0.24 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.